http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102399137-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_af59a592ee75817ee7b8998666426920 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C249-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C45-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C49-84 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C251-40 |
| filingDate | 2011-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2014-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eaf9cafb36da3c03365fd5ac90830d47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_296f96f7f2c39916ac136035ecf41a5c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b2de651e0e7f17d7c012307a33223c8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa2817148f13fc82321aba89f1eacfba http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0eaf252758a71e8e7224df7eedcaa087 |
| publicationDate | 2014-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-102399137-B |
| titleOfInvention | 1-substituted aryl-3-(3,4,5-trimethoxyphenyl)-1,2-propanedione compound and derivative thereof |
| abstract | The invention belongs to the technical field of medicine, and relates to 1-substituted aryl-3-(3,4,5-trimethoxyphenyl)-1,2-propanedione and derivatives of the 1-substituted aryl-3-(3,4,5-trimethoxyphenyl)-1,2-propanedione compound. The derivatives have a structure shown in the description, wherein X and Y are O, NOH, NOR, and NR; and R is C1-C6 alkyl. The invention also provides pharmaceutically acceptable nontoxic salts formed by the derivatives represented by the structural formula, and hydrates thereof. The pharmaceutically acceptable nontoxic salts include salts formed by the derivatives and acids. As a result of pharmacological activity tests, the derivatives have good tumor-inhibiting activities. The derivatives can be used in tumor cell antiblastics in the preparations of tumor inhibiting medicines. |
| priorityDate | 2011-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 89.